Company Filing History:
2 out of 3,923 
1 out of 832,843 Years Active: 2012-2013
Title: Innovations by Charles Voliva in PI-3 Kinase Inhibition
Introduction
Charles Voliva, an inventive mind based in Emeryville, CA, has made significant contributions to the field of pharmaceuticals with his innovative research focused on PI-3 kinase inhibitors. With a total of three patents to his name, Voliva's work plays a crucial role in developing therapeutic agents for treating proliferative diseases.
Latest Patents
Voliva's latest patents include a series of pyrimidine derivatives, specifically designed to act as phosphatidylinositol (PI) 3-kinase inhibitor compounds. These patents detail not only the compounds themselves but also their pharmaceutically acceptable salts and prodrugs. These new compounds can be administered either alone or in conjunction with at least one additional therapeutic agent, accompanied by suitable carriers. The focus of these innovations is the prophylaxis and treatment of proliferative diseases, which are marked by abnormal activity of growth factors, protein serine/threonine kinases, and phospholipid kinases.
Career Highlights
Throughout his career, Voliva has been associated with reputable companies such as Novartis AG, where he has significantly influenced drug discovery and development. His expertise and innovative approaches have been instrumental in pushing the boundaries of pharmaceutical research, creating vital solutions for complex medical challenges.
Collaborations
In his journey of innovation, Voliva has collaborated with notable professionals in the field, including Matthew T. Burger and Zhi-Jie Ni. These partnerships have further enhanced the scope of his research and amplified the impact of his discoveries on the pharmaceutical landscape.
Conclusion
Charles Voliva stands as a testament to the power of innovation in the pharmaceutical industry. His contributions, particularly in the development of PI-3 kinase inhibitors, underscore the potential for scientific advancements to lead to effective treatments for serious health conditions. As he continues to be active in his field, the future holds promising possibilities for further innovations born from his work.